TY - JOUR
T1 - Chinese expert consensus on the diagnosis and treatment of breast carcinoma in situ
AU - Chinese Expert Group on Diagnosis and Treatment of Breast Carcinoma in situ
AU - Sun, Q.
AU - Xu, B. H.
AU - Shao, Z. M.
PY - 2016/12/23
Y1 - 2016/12/23
N2 - In situ carcinomas of the breast constitute 15% to 30% of all newly diagnosed breast cancer cases. Although the concept of carcinoma in situ has been proposed for a long time, there is still a great controversy regarding the screening, diagnosis and treatment. This article attempts to reach some consensus on the management of ductal carcinoma in situ and lobular carcinoma in situ and provide references for clinicians in the following aspects: definition and classification, natural history and prognosis, diagnosis, local and systemic treatment for primary carcinoma in situ, recurrence risk and treatment approaches for recurrent cancers.
AB - In situ carcinomas of the breast constitute 15% to 30% of all newly diagnosed breast cancer cases. Although the concept of carcinoma in situ has been proposed for a long time, there is still a great controversy regarding the screening, diagnosis and treatment. This article attempts to reach some consensus on the management of ductal carcinoma in situ and lobular carcinoma in situ and provide references for clinicians in the following aspects: definition and classification, natural history and prognosis, diagnosis, local and systemic treatment for primary carcinoma in situ, recurrence risk and treatment approaches for recurrent cancers.
UR - https://www.scopus.com/pages/publications/85023601709
U2 - 10.3760/cma.j.issn.0253-3766.2016.12.011
DO - 10.3760/cma.j.issn.0253-3766.2016.12.011
M3 - 文章
C2 - 27998472
AN - SCOPUS:85023601709
SN - 0253-3766
VL - 38
SP - 942
EP - 947
JO - Zhonghua zhong liu za zhi [Chinese journal of oncology]
JF - Zhonghua zhong liu za zhi [Chinese journal of oncology]
IS - 12
ER -
